200 Participants Needed

HERCaRE App for Breast Cancer

LP
CT
Overseen ByClinical Trials Referral Office
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Mayo Clinic
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial examines whether a new mobile app called HERCaRE can help Black women who have survived breast cancer manage their health more effectively after treatment. The app provides educational content and resources tailored to their cultural needs. Participants will use the app for 4-6 weeks to determine if it improves their survivorship experience. This trial suits Black women who have completed active breast cancer treatment and have access to a smartphone or are open to using other digital access points. As an unphased trial, it offers participants the opportunity to contribute to innovative research that could enhance post-treatment care for others.

Will I have to stop taking my current medications?

The trial does not specify whether you need to stop taking your current medications. It seems focused on using a support app, so it's unlikely that you would need to change your medication routine.

What prior data suggests that the HERCaRE app is safe for improving survivorship among breast cancer survivors?

In a previous study, health apps like the HERCaRE app helped breast cancer patients manage side effects. Research shows that these digital tools are generally easy to use and do not cause serious side effects. The HERCaRE app provides support and education, not medication, reducing the risk of negative effects. This makes it a safe choice for those seeking to improve their breast cancer recovery experience.12345

Why are researchers excited about this trial?

The HERCaRE app is unique because it offers a digital approach to supportive care for breast cancer patients. Unlike traditional treatments that focus on medical interventions like surgery, chemotherapy, or radiation, this app aims to enhance patient well-being through accessible technology. Researchers are excited about its potential to provide personalized support, improve patients' quality of life, and empower them to manage their care more effectively from anywhere. This innovative method could complement existing treatments by addressing the emotional and psychological needs of patients, areas often underserved by traditional medical approaches.

What evidence suggests that the HERCaRE app is effective for improving survivorship among Black breast cancer survivors?

Research has shown that apps can greatly improve the lives of breast cancer patients. One study found that these apps help reduce anxiety, which is important for overall well-being. Mobile health apps also boost patients' confidence in managing their health. Another study found that using these apps can lead to better care, especially for those undergoing surgery. In this trial, participants will use the HERCaRE app, designed to offer culturally relevant support and resources, potentially helping Black breast cancer survivors thrive.56789

Who Is on the Research Team?

MS

Manisha Salinas, DrPH

Principal Investigator

Mayo Clinic

Are You a Good Fit for This Trial?

This trial is for self-identified Black women over 18 who have completed breast cancer treatment at least a month ago. They must live near the Mayo Clinic Florida and have smartphone access or be willing to use other resources to participate.

Inclusion Criteria

I identify as a Black or African American woman.
I live within the Mayo Clinic Florida area.
I learned about this study through a support group or community event, not directly from a hospital or clinic.
See 4 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants use the HERCaRE app, a virtual support platform, to improve survivorship among Black breast cancer survivors

4-6 weeks
Virtual engagement through app usage

Follow-up

Participants are monitored for survivorship engagement and adherence to follow-up care

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • HERCaRE Application
Trial Overview The HERCaRE app, designed for Black breast cancer survivors, is being tested. It offers culturally tailored education, interactive content, and health equity resources aimed at improving survivorship after treatment.
How Is the Trial Designed?
1Treatment groups
Experimental Treatment
Group I: Supportive Care (HERCaRE app)Experimental Treatment4 Interventions

Find a Clinic Near You

Who Is Running the Clinical Trial?

Mayo Clinic

Lead Sponsor

Trials
3,427
Recruited
3,221,000+

Citations

HERCaRE App for Breast CancerThis N/A medical study run by Mayo Clinic is evaluating whether HERCaRE Application will have tolerable side effects & efficacy for patients with Breast ...
Effects of using app-based interventions on quality of life ...The present study found that app-based interventions significantly improved anxiety symptoms in breast cancer patients, but the improvement in ...
Evaluating the Effectiveness of a Mobile App for Breast ...The mobile app for breast cancer self-management, CAMA, was deemed feasible and showed promise in improving the patients' self-efficacy.
Expert evaluation of mobile health apps for breast cancer ...This study aimed to evaluate the quality of breast cancer mobile health (m-health) applications using the Mobile Application Rating Scale (MARS)
Evaluation of the Effects of Mobile Applications on the Care ...Mobile health applications were found to significantly improve care outcomes for breast cancer patients undergoing surgery.
Virtual Support Platform (HERCaRE Application) for the ...The HERCaRE platform is a mobile-friendly app that includes culturally tailored educational materials, interactive content, and health equity resources to help ...
7.pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov/39642329/
Symptom Monitoring App Use Associated With Medication ...Purpose: Oral adjuvant endocrine therapy (AET) reduces the risk of cancer recurrence and death for women with hormone receptor-positive (HR+) ...
Cancer Treatment ReviewsFavorable impact of therapy management by an interactive eHealth system on severe adverse events in patients with hormone receptor-positive, HER2-negative ...
Clinical trial of innovative health app reimagines care for ...A clinical trial testing an innovative health app, which aims to prevent cardiotoxicity and improve the physical and mental health of breast cancer patients ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of ServiceยทPrivacy PolicyยทCookiesยทSecurity